Initiation of renal replacement therapy tended to decrease, but did not reach to statistical significance (HR 0.84, 95% CI 0.631.12)
Heres what could happen: Weight loss slows down: Junk food has calories, and even smaller portions pile up over time
Healthcare providers in the region are also increasingly recognizing obesity as a clinical condition that requires structured treatment rather than lifestyle counseling alone
Finally, check the cap and the overall feel
By activating GLP-1, semaglutide helps: Reduce appetite Increase fullness Slow digestion Improve blood sugar control This targeted approach has helped millions of people achieve meaningful weight loss and better metabolic health
This can recalibrate expectations and help microdosers understand that while their approach minimizes side effects, it also significantly extends the timeline to therapeutic levels